Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.
We have previously shown that in utero nicotine exposure causes impaired fertility, follicle immaturity, and ovarian dysfunction in adult female rat offspring. These characteristics overtly resemble the clinical profile of polycystic ovarian syndrome (PCOS) and recent studies have shown that thiazolidinediones such as rosiglitazone improve fertility in women with PCOS but the mechanism is not well defined. Our goal was to examine whether rosiglitazone would (1) ameliorate the altered ovarian physiology that occurs following fetal and neonatal exposure to nicotine and (2) to examine whether this could be due to normalization of ovarian vascularization. At weaning, offspring of nicotine-exposed dams were given either vehicle (NV) or rosiglitazone (3 mg kg(-1) day(-1); NR). Offspring of saline-exposed dams received vehicle (SV). Tissues were collected when the female offspring reached 26 weeks of age. NV animals had reduced granulosa cell proliferation and increased ovarian cell apoptosis. Treatment with rosiglitazone increased proliferation, and decreased apoptosis, compared NV animals. NV animals had decreased ovarian vascularity relative to controls, whereas NR animals had an intermediate level of ovarian vessel density. Moreover, ovaries from NV animals had decreased levels of the pro-angiogenic growth factors vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF both of which were increased with rosiglitazone treatment. Rosiglitazone reversed some of the nicotine effects in the ovary and increased ovarian vascularization, follicle maturation and improved oocyte competence. Rosiglitazone may be an important treatment option for PCOS and the present study provides a potential mechanism by which rosiglitazone may have beneficial effects on fertility in these patients.
Petrik
J J
JJ
Department of Biomedical Sciences, University of Guelph, Guelph, ON, N1G 2W1, Canada. jpetrik@uoguelph.ca
Gerstein
H C
HC
Cesta
C E
CE
Kellenberger
L D
LD
Alfaidy
N
N
Holloway
A C
AC
D000818:Animals; D000831:Animals, Newborn; D001808:Blood Vessels / Q000187:drug effects; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical; D005260:Female; D005298:Fertility / Q000187:drug effects* / Q000502:physiology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007247:Infertility, Female / Q000503:physiopathology; D018811:Maternal Exposure / Q000009:adverse effects; D009538:Nicotine / Q000009:adverse effects*; D010053:Ovary / Q000098:blood supply / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D017208:Rats, Wistar; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D009538:Nicotine
Acta Obstet Gynecol Scand. 2006;85(11):1331-7
17091413
Am J Pathol. 2003 Jun;162(6):1881-93
12759245
Food Chem Toxicol. 2002 Jan;40(1):93-104
11731039
Am J Epidemiol. 2004 Jan 1;159(1):49-58
14693659
Epidemiology. 2003 May;14(3):278-86
12859027
Mol Hum Reprod. 2007 Oct;13(10):729-36
17804434
Neuroreport. 2002 Aug 27;13(12):1509-13
12218695
J Clin Endocrinol Metab. 2005 Jan;90(1):60-5
15483106
PPAR Res. 2006;2006:73986
17347533
Indian J Physiol Pharmacol. 1998 Oct;42(4):503-8
10874351
Gynecol Endocrinol. 2006 Aug;22(8):465-70
17012110
Hum Exp Toxicol. 2007 Jul;26(7):595-602
17884964
Circulation. 2004 Mar 23;109(11):1392-400
14993120
Fertil Steril. 2005 Apr;83 Suppl 1:1093-9
15831280
Am J Epidemiol. 1998 Nov 15;148(10):992-7
9829871
Hum Reprod. 2005 Dec;20(12):3333-40
16123091
J Cell Physiol. 2007 Mar;210(3):807-18
17154366
Am J Epidemiol. 1989 May;129(5):1072-8
2705427
Blood. 2008 Feb 1;111(3):1227-33
17962514
Fertil Steril. 2004 Apr;81(4):1181-6
15066502
Fertil Steril. 2004 Oct;82 Suppl 3:1101-5
15474081
Neuroscience. 2005;132(2):325-33
15802186
Reprod Toxicol. 1994 Jul-Aug;8(4):325-31
7949758
Hum Reprod Update. 2005 Jan-Feb;11(1):43-57
15601728
Atherosclerosis. 2005 Nov;183(1):163-7
15907852
Endocrine. 2006 Oct;30(2):213-6
17322582
Am J Obstet Gynecol. 2007 Apr;196(4):402.e1-10; discussion 402.e10-1
17403436
Hum Reprod. 2005 Sep;20(9):2559-66
15919771
Diabetes Obes Metab. 2008 Sep;10(9):763-71
17970760
Fertil Steril. 2003 Mar;79(3):562-6
12620440
Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 1):142-56
12052000
Endocrine. 2007 Jun;31(3):254-9
17906372
Hum Reprod. 1998 Jun;13(6):1532-9
9688387
Placenta. 2007 Oct;28(10):1049-58
17531315
Endocrinology. 2004 Jun;145(6):2896-905
14988387
J Biol Chem. 2007 Dec 21;282(51):37006-15
17965419
Biol Reprod. 2005 May;72(5):1071-8
15616224
Biochem Biophys Res Commun. 2007 Jul 20;359(1):63-9
17531201